Skip to Content Skip to Content
India Today
K-12 Dive
This baby’s future was bleak. Then he became a medical first
USA Today

This baby’s future was bleak. Then he became a medical first

A team from the Perelman School of Medicine and Children’s Hospital of Philadelphia led by Kiran Musunuru and Rebecca Ahrens-Nicklas has developed a customized CRISPR gene editing therapy that could be scaled to fit the needs of individual patients.

May 15, 2025

For the first time, a CRISPR drug treats a child’s unique mutation
The Economist

For the first time, a CRISPR drug treats a child’s unique mutation

Kiran Musunuru and Rebecca Ahrens-Nicklas of the Perelman School of Medicine led a team from Penn and the Children’s Hospital of Philadelphia that used gene editing to heal a baby with a rare genetic condition.

May 16, 2025

euronews
Subscribe to